Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

PURE Bioscience, Inc. (PURE)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

0.0700

-0.0090

(-11.39%)

At close: 03:07PM EDT

Loading interactive chart…

Business Wire
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results
EL CAJON, Calif., March 18, 2024--PURE Bioscience, Inc. (OTCQB: PURE) ("PURE," the "Company" or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal second quarter ended January 31, 2024.
Business Wire
PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results
EL CAJON, Calif., December 14, 2023--PURE Bioscience, Inc. (OTCQB: PURE) ("PURE," the "Company" or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2023.
Business Wire
PURE Bioscience Reports Fiscal 2023 Financial Results
EL CAJON, Calif., October 30, 2023--PURE Bioscience, Inc. (OTCQB: PURE) ("PURE," the "Company" or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal year ended July 31, 2023.